110863,Admission,O
110863,Date,O
110863,:,O
110863,[,O
110863,**2108-12-11**,O
110863,],O
110863,Discharge,O
110863,Date,O
110863,:,O
110863,[,O
110863,**2108-12-16**,O
110863,],O
110863,Service,O
110863,:,O
110863,MEDICINE,O
110863,Allergies,O
110863,:,O
110863,Niacin,B-Drug
110863,Attending,O
110863,:,O
110863,[,O
110863,**First,O
110863,Name3,O
110863,(,O
110863,LF,O
110863,),O
110863,2024**,O
110863,],O
110863,Chief,O
110863,Complaint,O
110863,:,O
110863,generalized,O
110863,weakness,O
110863,",",O
110863,odynophagia,O
110863,Major,O
110863,Surgical,O
110863,or,O
110863,Invasive,O
110863,Procedure,O
110863,:,O
110863,HD,O
110863,History,O
110863,of,O
110863,Present,O
110863,Illness,O
110863,:,O
110863,85-year-old,O
110863,man,O
110863,with,O
110863,a,O
110863,history,O
110863,of,O
110863,recently,O
110863,diagnosed,O
110863,Kaposi's,O
110863,sarcoma,O
110863,with,O
110863,visceral,O
110863,involvement,O
110863,",",O
110863,duodenal,O
110863,ulcer,O
110863,",",O
110863,ESRD,O
110863,not,O
110863,on,O
110863,HD,O
110863,",",O
110863,HTN,O
110863,",",O
110863,HL,O
110863,",",O
110863,sCHF,O
110863,w/EF,O
110863,40,O
110863,%,O
110863,",",O
110863,recent,O
110863,admission,O
110863,for,O
110863,GIB,O
110863,",",O
110863,is,O
110863,transferred,O
110863,here,O
110863,from,O
110863,OSH,O
110863,for,O
110863,generalized,O
110863,weakness,O
110863,",",O
110863,confusion,O
110863,",",O
110863,odynophagia,O
110863,.,O
110863,.,O
110863,Patient,O
110863,received,O
110863,his,O
110863,cycle,O
110863,2,O
110863,of,O
110863,paclitaxel,B-Drug
110863,on,O
110863,[,O
110863,**2108-12-5**,O
110863,],O
110863,and,O
110863,has,O
110863,been,O
110863,experiencing,O
110863,odynophagia,O
110863,from,O
110863,mucositis,O
110863,.,O
110863,For,O
110863,the,O
110863,past,O
110863,few,O
110863,days,O
110863,he,O
110863,has,O
110863,felt,O
110863,``,O
110863,not,O
110863,well,O
110863,'',O
110863,at,O
110863,home,O
110863,",",O
110863,complaining,O
110863,of,O
110863,intermittent,O
110863,shortness,O
110863,of,O
110863,breath,O
110863,",",O
110863,odynophagia,O
110863,and,O
110863,dysphagia,O
110863,.,O
110863,He,O
110863,presented,O
110863,to,O
110863,[,O
110863,**Hospital6,O
110863,10353**,O
110863,],O
110863,on,O
110863,[,O
110863,**2108-12-10**,O
110863,],O
110863,.,O
110863,There,O
110863,",",O
110863,he,O
110863,was,O
110863,found,O
110863,to,O
110863,have,O
110863,pancytopenia,O
110863,.,O
110863,Initially,O
110863,CHF,O
110863,exacerbation,O
110863,was,O
110863,suspected,O
110863,given,O
110863,clinical,O
110863,status,O
110863,and,O
110863,BNP,O
110863,of,O
110863,"65,987",O
110863,.,O
110863,However,O
110863,",",O
110863,chest,O
110863,CT,O
110863,without,O
110863,contrast,O
110863,showed,O
110863,moderate,O
110863,pleural,O
110863,effusion,O
110863,with,O
110863,right,O
110863,lower,O
110863,lobe,O
110863,atelectasis,O
110863,",",O
110863,but,O
110863,no,O
110863,evidence,O
110863,of,O
110863,pulmonary,O
110863,edema,O
110863,.,O
110863,Pneumonia,B-Reason
110863,was,O
110863,suspected,O
110863,and,O
110863,patient,O
110863,was,O
110863,started,O
110863,on,O
110863,ceftriaxone,B-Drug
110863,and,O
110863,vancomycin,B-Drug
110863,.,I-Drug
110863,His,O
110863,home,O
110863,furosemide,B-Drug
110863,was,O
110863,held,O
110863,.,O
110863,.,O
110863,While,O
110863,at,O
110863,[,O
110863,**Hospital6,O
110863,10353**,O
110863,],O
110863,",",O
110863,patient,O
110863,started,O
110863,to,O
110863,be,O
110863,delirious,O
110863,",",O
110863,not,O
110863,knowing,O
110863,where,O
110863,he,O
110863,was,O
110863,",",O
110863,attempting,O
110863,to,O
110863,get,O
110863,out,O
110863,of,O
110863,bed,O
110863,frequently,O
110863,",",O
110863,and,O
110863,at,O
110863,one,O
110863,point,O
110863,falling,O
110863,without,O
110863,head,O
110863,trauma,O
110863,",",O
110863,per,O
110863,his,O
110863,family,O
110863,.,O
110863,At,O
110863,OSH,O
110863,",",O
110863,hct,O
110863,23,O
110863,and,O
110863,plts,O
110863,35,O
110863,.,O
110863,His,O
110863,CXR,O
110863,showed,O
110863,bilateral,O
110863,pleural,O
110863,effusions,O
110863,.,O
110863,He,O
110863,was,O
110863,started,O
110863,on,O
110863,ceftriaxone,B-Drug
110863,and,O
110863,vancomycin,B-Drug
110863,empirically,O
110863,.,O
110863,.,O
110863,Review,O
110863,of,O
110863,Systems,O
110863,:,O
110863,(,O
110863,+,O
110863,),O
110863,Per,O
110863,HPI,O
110863,(,O
110863,-,O
110863,),O
110863,Denies,O
110863,fever,O
110863,",",O
110863,chills,O
110863,",",O
110863,night,O
110863,sweats,O
110863,",",O
110863,recent,O
110863,weight,O
110863,loss,O
110863,or,O
110863,gain,O
110863,.,O
110863,Denies,O
110863,blurry,O
110863,vision,O
110863,",",O
110863,diplopia,O
110863,",",O
110863,loss,O
110863,of,O
110863,vision,O
110863,",",O
110863,photophobia,O
110863,.,O
110863,Denies,O
110863,headache,O
110863,",",O
110863,sinus,O
110863,tenderness,O
110863,",",O
110863,rhinorrhea,O
110863,or,O
110863,congestion,O
110863,.,O
110863,Denies,O
110863,chest,O
110863,pain,O
110863,or,O
110863,tightness,O
110863,",",O
110863,palpitations,O
110863,",",O
110863,lower,O
110863,extremity,O
110863,edema,O
110863,.,O
110863,Denies,O
110863,cough,O
110863,",",O
110863,shortness,O
110863,of,O
110863,breath,O
110863,",",O
110863,or,O
110863,wheezes,O
110863,.,O
110863,Denies,O
110863,nausea,O
110863,",",O
110863,vomiting,O
110863,",",O
110863,diarrhea,O
110863,",",O
110863,constipation,O
110863,",",O
110863,abdominal,O
110863,pain,O
110863,",",O
110863,melena,O
110863,",",O
110863,hematemesis,O
110863,",",O
110863,hematochezia,O
110863,.,O
110863,Denies,O
110863,abnormal,O
110863,bleeding,O
110863,",",O
110863,bruising,O
110863,",",O
110863,lymphadenopathy,O
110863,.,O
110863,Denies,O
110863,dysuria,O
110863,",",O
110863,stool,O
110863,or,O
110863,urine,O
110863,incontinence,O
110863,.,O
110863,Denies,O
110863,arthralgias,O
110863,or,O
110863,myalgias,O
110863,.,O
110863,Denies,O
110863,rashes,O
110863,or,O
110863,skin,O
110863,breakdown,O
110863,.,O
110863,No,O
110863,numbness/tingling,O
110863,in,O
110863,extremities,O
110863,.,O
110863,All,O
110863,other,O
110863,systems,O
110863,negative,O
110863,.,O
110863,Past,O
110863,Medical,O
110863,History,O
110863,:,O
110863,Past,O
110863,Oncologic,O
110863,History,O
110863,:,O
110863,Kaposi,O
110863,'s,O
110863,sarcoma,O
110863,diagnosed,O
110863,by,O
110863,LLE,O
110863,biopsy,O
110863,[,O
110863,**2108-10-23**,O
110863,],O
110863,by,O
110863,dermatology,O
110863,;,O
110863,evidence,O
110863,of,O
110863,visceral,O
110863,involvement,O
110863,on,O
110863,GI,O
110863,capsule,O
110863,study,O
110863,[,O
110863,**2108-10-30**,O
110863,],O
110863,.,O
110863,Admitted,O
110863,by,O
110863,Dr.,O
110863,[,O
110863,**First,O
110863,Name8,O
110863,(,O
110863,NamePattern2,O
110863,),O
110863,916**,O
110863,],O
110863,[,O
110863,**Last,O
110863,Name,O
110863,(,O
110863,NamePattern1,O
110863,),O
110863,**,O
110863,],O
110863,on,O
110863,[,O
110863,**2108-11-14**,O
110863,],O
110863,for,O
110863,cycle,O
110863,1,O
110863,of,O
110863,Taxol,B-Drug
110863,.,I-Drug
110863,.,O
110863,Other,O
110863,Past,O
110863,Medical,O
110863,History,O
110863,:,O
110863,Upper,O
110863,GI,O
110863,bleed,O
110863,though,O
110863,secondary,O
110863,to,O
110863,Dieulafoy,O
110863,'s,O
110863,lesion,O
110863,ESRD,O
110863,with,O
110863,right,O
110863,sided,O
110863,AV,O
110863,fistula,O
110863,",",O
110863,not,O
110863,on,O
110863,HD,O
110863,CAD,O
110863,s/p,O
110863,CABGx3,O
110863,in,O
110863,[,O
110863,**2095**,O
110863,],O
110863,",",O
110863,s/p,O
110863,SVG,O
110863,to,O
110863,RCA,O
110863,stent,O
110863,[,O
110863,**2099**,O
110863,],O
110863,",",O
110863,SVG,O
110863,to,O
110863,OM,O
110863,stent,O
110863,[,O
110863,**2106**,O
110863,],O
110863,.,O
110863,Recent,O
110863,p-mibi,O
110863,with,O
110863,moderate,O
110863,ischemia,O
110863,in,O
110863,anterior,O
110863,wall,O
110863,in,O
110863,[,O
110863,**6-7**,O
110863,],O
110863,",",O
110863,cath,O
110863,deferred,O
110863,due,O
110863,to,O
110863,renal,O
110863,function,O
110863,.,O
110863,CHF,O
110863,",",O
110863,chronic,O
110863,systolic,O
110863,and,O
110863,diastolic,O
110863,",",O
110863,EF,O
110863,40,O
110863,%,O
110863,on,O
110863,recent,O
110863,P-mibi,O
110863,Moderate,O
110863,Aortic,O
110863,stenosis,O
110863,Anemia,O
110863,Hearing,O
110863,impairment,O
110863,Right,O
110863,AV,O
110863,fistula,O
110863,placed,O
110863,[,O
110863,**2108-5-21**,O
110863,],O
110863,Hyperparathyroidism,O
110863,due,O
110863,to,O
110863,ESRD,O
110863,Obesity,O
110863,HTN,O
110863,HL,O
110863,BPH,O
110863,Intraocular,O
110863,lens,O
110863,Social,O
110863,History,O
110863,:,O
110863,Lives,O
110863,at,O
110863,home,O
110863,on,O
110863,[,O
110863,**Location,O
110863,(,O
110863,un,O
110863,),O
110863,448**,O
110863,],O
110863,of,O
110863,home,O
110863,with,O
110863,wife,O
110863,who,O
110863,has,O
110863,early,O
110863,[,O
110863,**Name,O
110863,(,O
110863,NI,O
110863,),O
110863,11964**,O
110863,],O
110863,.,O
110863,Has,O
110863,a,O
110863,caretaker,O
110863,who,O
110863,is,O
110863,in,O
110863,every,O
110863,other,O
110863,day,O
110863,to,O
110863,help,O
110863,with,O
110863,medications,O
110863,",",O
110863,appointments,O
110863,.,O
110863,Previously,O
110863,worked,O
110863,for,O
110863,local,O
110863,school,O
110863,system,O
110863,",",O
110863,fought,O
110863,in,O
110863,the,O
110863,infantry,O
110863,in,O
110863,WWII,O
110863,in,O
110863,[,O
110863,**Country,O
110863,480**,O
110863,],O
110863,and,O
110863,in,O
110863,[,O
110863,**Country,O
110863,2559**,O
110863,],O
110863,.,O
110863,Distant,O
110863,history,O
110863,of,O
110863,tobacco,O
110863,use,O
110863,60,O
110863,years,O
110863,ago,O
110863,",",O
110863,1ppd,O
110863,for,O
110863,2,O
110863,years,O
110863,",",O
110863,denies,O
110863,EtOH,O
110863,and,O
110863,illicit,O
110863,drug,O
110863,use,O
110863,.,O
110863,Family,O
110863,History,O
110863,:,O
110863,Sister,O
110863,w/brain,O
110863,CA,O
110863,",",O
110863,brother,O
110863,w/,O
110863,[,O
110863,**Name2,O
110863,(,O
110863,NI,O
110863,),O
110863,499**,O
110863,],O
110863,CA,O
110863,",",O
110863,both,O
110863,deceased,O
110863,.,O
110863,Brother,O
110863,died,O
110863,of,O
110863,sudden,O
110863,cardiac,O
110863,death,O
110863,at,O
110863,age,O
110863,56,O
110863,.,O
110863,Father,O
110863,died,O
110863,at,O
110863,age,O
110863,80,O
110863,of,O
110863,?,O
110863,CVA,O
110863,.,O
110863,Mother,O
110863,died,O
110863,of,O
110863,[,O
110863,**Name,O
110863,(,O
110863,NI,O
110863,),O
110863,5895**,O
110863,],O
110863,in,O
110863,her,O
110863,80,O
110863,'s,O
110863,.,O
110863,Physical,O
110863,Exam,O
110863,:,O
110863,VS,O
110863,:,O
110863,T,O
110863,99.1,O
110863,",",O
110863,BP,O
110863,122/70,O
110863,",",O
110863,HR,O
110863,78,O
110863,",",O
110863,RR,O
110863,24,O
110863,",",O
110863,98,O
110863,%,O
110863,RA,O
110863,GEN,O
110863,:,O
110863,Elderly,O
110863,man,O
110863,in,O
110863,NAD,O
110863,",",O
110863,awake,O
110863,HEENT,O
110863,:,O
110863,EOMI,O
110863,",",O
110863,PERRL,O
110863,",",O
110863,sclera,O
110863,anicteric,O
110863,",",O
110863,conjunctivae,O
110863,clear,O
110863,",",O
110863,OP,O
110863,moist,O
110863,and,O
110863,without,O
110863,lesion,O
110863,NECK,O
110863,:,O
110863,Supple,O
110863,",",O
110863,no,O
110863,JVD,O
110863,CV,O
110863,:,O
110863,Reg,O
110863,rate,O
110863,",",O
110863,normal,O
110863,S1,O
110863,",",O
110863,S2,O
110863,.,O
110863,No,O
110863,m/r/g,O
110863,.,O
110863,CHEST,O
110863,:,O
110863,Resp,O
110863,were,O
110863,unlabored,O
110863,",",O
110863,no,O
110863,accessory,O
110863,muscle,O
110863,use,O
110863,.,O
110863,Bibasilar,O
110863,crackles,O
110863,R,O
110863,>,O
110863,L,O
110863,",",O
110863,scattered,O
110863,expiratory,O
110863,wheezes,O
110863,ABD,O
110863,:,O
110863,Soft,O
110863,",",O
110863,NT,O
110863,",",O
110863,ND,O
110863,",",O
110863,no,O
110863,HSM,O
110863,",",O
110863,bowel,O
110863,sounds,O
110863,present,O
110863,MSK,O
110863,:,O
110863,normal,O
110863,muscle,O
110863,tone,O
110863,and,O
110863,bulk,O
110863,EXT,O
110863,:,O
110863,1+,O
110863,bilateraly,O
110863,LE,O
110863,edema,O
110863,to,O
110863,mid-shin,O
110863,",",O
110863,2+,O
110863,DP/PT,O
110863,bilaterally,O
110863,SKIN,O
110863,:,O
110863,No,O
110863,rash,O
110863,",",O
110863,warm,O
110863,skin,O
110863,NEURO,O
110863,:,O
110863,oriented,O
110863,to,O
110863,name,O
110863,",",O
110863,``,O
110863,hospital,O
110863,",",O
110863,'',O
110863,but,O
110863,not,O
110863,date,O
110863,;,O
110863,answered,O
110863,'',O
110863,[,O
110863,**Doctor,O
110863,First,O
110863,Name,O
110863,4375**,O
110863,],O
110863,'',O
110863,for,O
110863,US,O
110863,president,O
110863,;,O
110863,normal,O
110863,attention,O
110863,but,O
110863,hard,O
110863,of,O
110863,hearing,O
110863,;,O
110863,CN,O
110863,II-XII,O
110863,intact,O
110863,",",O
110863,5/5,O
110863,strength,O
110863,throughout,O
110863,but,O
110863,exam,O
110863,not,O
110863,accurate,O
110863,due,O
110863,to,O
110863,patient,O
110863,'s,O
110863,not,O
110863,fully,O
110863,cooperating,O
110863,",",O
110863,intact,O
110863,sensation,O
110863,to,O
110863,light,O
110863,touch,O
110863,PSYCH,O
110863,:,O
110863,slightly,O
110863,confused,O
110863,",",O
110863,asking,O
110863,family,O
110863,members,O
110863,about,O
110863,non-relevant,O
110863,things,O
110863,LYMPH,O
110863,:,O
110863,no,O
110863,cervical,O
110863,",",O
110863,axillary,O
110863,",",O
110863,inguinal,O
110863,LAD,O
110863,Pertinent,O
110863,Results,O
110863,:,O
110863,[,O
110863,**2108-12-12**,O
110863,],O
110863,12:08AM,O
110863,BLOOD,O
110863,WBC-0.3*,O
110863,#,O
110863,RBC-3.17*,O
110863,Hgb-9.2*,O
110863,Hct-26.0*,O
110863,MCV-82,O
110863,MCH-29.1,O
110863,MCHC-35.4*,O
110863,RDW-16.7*,O
110863,Plt,O
110863,Ct-47*,O
110863,#,O
110863,[,O
110863,**2108-12-12**,O
110863,],O
110863,12:08AM,O
110863,BLOOD,O
110863,Plt,O
110863,Ct-47*,O
110863,#,O
110863,[,O
110863,**2108-12-12**,O
110863,],O
110863,12:08AM,O
110863,BLOOD,O
110863,PT-13.7*,O
110863,PTT-26.8,O
110863,INR,O
110863,(,O
110863,PT,O
110863,),O
110863,-1.2*,O
110863,[,O
110863,**2108-12-12**,O
110863,],O
110863,12:08AM,O
110863,BLOOD,O
110863,Glucose-118*,O
110863,UreaN-133*,O
110863,Creat-4.1*,O
110863,Na-144,O
110863,K-4.3,O
110863,Cl-105,O
110863,HCO3-24,O
110863,AnGap-19,O
110863,.,O
110863,IMAGING,O
110863,:,O
110863,#,O
110863,Chest,O
110863,CT,O
110863,(,O
110863,OSH,O
110863,),O
110863,moderate,O
110863,R,O
110863,pleural,O
110863,effusion,O
110863,with,O
110863,RLL,O
110863,atelectasis,O
110863,#,O
110863,CXR,O
110863,[,O
110863,**12-14**,O
110863,],O
110863,:,O
110863,FINDINGS,O
110863,:,O
110863,In,O
110863,comparison,O
110863,with,O
110863,the,O
110863,study,O
110863,of,O
110863,[,O
110863,**12-12**,O
110863,],O
110863,",",O
110863,there,O
110863,is,O
110863,layering,O
110863,of,O
110863,substantial,O
110863,right,O
110863,pleural,O
110863,effusion,O
110863,.,O
110863,Probably,O
110863,smaller,O
110863,left,O
110863,pleural,O
110863,effusion,O
110863,shows,O
110863,layering,O
110863,as,O
110863,well,O
110863,.,O
110863,Continued,O
110863,enlargement,O
110863,of,O
110863,the,O
110863,cardiac,O
110863,silhouette,O
110863,with,O
110863,evidence,O
110863,of,O
110863,pulmonary,O
110863,vascular,O
110863,congestion,O
110863,.,O
110863,Underlying,O
110863,lungs,O
110863,are,O
110863,difficult,O
110863,to,O
110863,evaluate,O
110863,",",O
110863,though,O
110863,there,O
110863,are,O
110863,probably,O
110863,at,O
110863,least,O
110863,atelectatic,O
110863,changes,O
110863,at,O
110863,both,O
110863,bases,O
110863,.,O
110863,#,O
110863,CXR,O
110863,[,O
110863,**12-12**,O
110863,],O
110863,:,O
110863,IMPRESSION,O
110863,:,O
110863,Findings,O
110863,suggestive,O
110863,of,O
110863,a,O
110863,pleural,O
110863,effusion,O
110863,on,O
110863,the,O
110863,right,O
110863,with,O
110863,opacities,O
110863,that,O
110863,can,O
110863,likely,O
110863,be,O
110863,attributed,O
110863,to,O
110863,atelectasis,O
110863,.,O
110863,Pneumonia,O
110863,can,O
110863,not,O
110863,be,O
110863,completely,O
110863,excluded,O
110863,",",O
110863,however,O
110863,.,O
110863,Follow-up,O
110863,radiographs,O
110863,may,O
110863,be,O
110863,helpful,O
110863,for,O
110863,continued,O
110863,evaluation,O
110863,.,O
110863,Brief,O
110863,Hospital,O
110863,Course,O
110863,:,O
110863,85-year-old,O
110863,man,O
110863,with,O
110863,Kaposi,O
110863,'s,O
110863,sarcoma,O
110863,with,O
110863,visceral,O
110863,involvement,O
110863,",",O
110863,CHF,O
110863,",",O
110863,CKD,O
110863,presents,O
110863,with,O
110863,confusion,O
110863,",",O
110863,dyspnea,O
110863,",",O
110863,odynophagia,O
110863,",",O
110863,generalized,O
110863,weakness,O
110863,.,O
110863,.,O
110863,#,O
110863,.,O
110863,Goals,O
110863,of,O
110863,Care,O
110863,:,O
110863,Patient,O
110863,was,O
110863,transferred,O
110863,to,O
110863,the,O
110863,ICU,O
110863,for,O
110863,hypoxia,O
110863,to,O
110863,the,O
110863,high,O
110863,80s,O
110863,from,O
110863,pulmonary,O
110863,edema,O
110863,and,O
110863,the,O
110863,plan,O
110863,to,O
110863,initiate,O
110863,dialysis,O
110863,to,O
110863,remove,O
110863,fluid,O
110863,.,O
110863,The,O
110863,patient,O
110863,did,O
110863,receive,O
110863,one,O
110863,round,O
110863,of,O
110863,dialysis,O
110863,before,O
110863,he,O
110863,and,O
110863,his,O
110863,family,O
110863,decided,O
110863,to,O
110863,change,O
110863,his,O
110863,goals,O
110863,of,O
110863,care,O
110863,.,O
110863,While,O
110863,in,O
110863,the,O
110863,ICU,O
110863,",",O
110863,it,O
110863,was,O
110863,decided,O
110863,that,O
110863,the,O
110863,patient,O
110863,would,O
110863,be,O
110863,made,O
110863,comfort,O
110863,measures,O
110863,only,O
110863,.,O
110863,The,O
110863,patient,O
110863,was,O
110863,started,O
110863,on,O
110863,a,O
110863,Morphine,B-Drug
110863,drip,O
110863,",",O
110863,Benadryl,B-Drug
110863,for,O
110863,itching,B-Reason
110863,related,I-Reason
110863,uremia,I-Reason
110863,",",I-Reason
110863,and,O
110863,Haldol,B-Drug
110863,for,O
110863,terminal,B-Reason
110863,delirium,I-Reason
110863,.,I-Reason
110863,The,O
110863,patient,O
110863,was,O
110863,subsequently,O
110863,transfered,O
110863,to,O
110863,the,O
110863,oncology,O
110863,inpatient,O
110863,service,O
110863,.,O
110863,Pt,O
110863,expired,O
110863,the,O
110863,following,O
110863,night,O
110863,.,O
110863,.,O
110863,#,O
110863,.,O
110863,Dyspnea,O
110863,:,O
110863,Patient,O
110863,presented,O
110863,with,O
110863,some,O
110863,wheezing,O
110863,on,O
110863,exam,O
110863,",",O
110863,bilateral,O
110863,crackles,O
110863,R,O
110863,>,O
110863,L,O
110863,.,O
110863,CT,O
110863,showed,O
110863,right-sided,O
110863,pleural,O
110863,effusion,O
110863,.,O
110863,Intermittently,O
110863,tachypneic,O
110863,but,O
110863,with,O
110863,good,O
110863,O2,O
110863,saturation,O
110863,.,O
110863,There,O
110863,is,O
110863,no,O
110863,clear,O
110863,evidence,O
110863,of,O
110863,pneumonia,O
110863,.,O
110863,Patient,O
110863,does,O
110863,not,O
110863,have,O
110863,significant,O
110863,coughs,O
110863,and,O
110863,the,O
110863,chest,O
110863,CT,O
110863,showed,O
110863,no,O
110863,clear,O
110863,infiltrate,O
110863,.,O
110863,Antibiotics,B-Drug
110863,were,O
110863,discontinued,O
110863,on,O
110863,the,O
110863,oncology,O
110863,service,O
110863,.,O
110863,The,O
110863,patient,O
110863,received,O
110863,nebs,B-Drug
110863,prn,O
110863,.,O
110863,Patient,O
110863,further,O
110863,received,O
110863,Furosemide,B-Drug
110863,given,O
110863,concern,O
110863,for,O
110863,CHF,B-Reason
110863,on,O
110863,exam,O
110863,.,O
110863,Pt,O
110863,had,O
110863,one,O
110863,round,O
110863,of,O
110863,dialysis,O
110863,but,O
110863,did,O
110863,not,O
110863,resolve,O
110863,pt,O
110863,'s,O
110863,tachypnea,O
110863,.,O
110863,.,O
110863,#,O
110863,.,O
110863,Confusion,O
110863,:,O
110863,Not,O
110863,at,O
110863,home,O
110863,but,O
110863,started,O
110863,being,O
110863,delirious,O
110863,at,O
110863,[,O
110863,**Hospital1,O
110863,9487**,O
110863,],O
110863,.,O
110863,Might,O
110863,be,O
110863,due,O
110863,to,O
110863,hospitalization-related,O
110863,delirium,O
110863,in,O
110863,an,O
110863,elderly,O
110863,person,O
110863,",",O
110863,CHF,O
110863,exacerbation,O
110863,",",O
110863,pneumonia,O
110863,.,O
110863,Head,O
110863,bleed,O
110863,is,O
110863,a,O
110863,possible,O
110863,cause,O
110863,given,O
110863,thrombocytopenia,O
110863,.,O
110863,Uremia,O
110863,(,O
110863,urea,O
110863,>,O
110863,100,O
110863,),O
110863,from,O
110863,CKD,O
110863,was,O
110863,ultimately,O
110863,presumed,O
110863,to,O
110863,be,O
110863,the,O
110863,most,O
110863,likely,O
110863,cause,O
110863,.,O
110863,.,O
110863,#,O
110863,.,O
110863,HTN,B-Reason
110863,:,I-Reason
110863,Normotensive,O
110863,on,O
110863,admission,O
110863,.,O
110863,The,O
110863,patient,O
110863,was,O
110863,continued,O
110863,on,O
110863,Hydralazine,B-Drug
110863,",",I-Drug
110863,Labetolol,O
110863,and,O
110863,Ranolazine,B-Drug
110863,initially,O
110863,",",O
110863,though,O
110863,these,O
110863,meds,O
110863,were,O
110863,held,O
110863,for,O
110863,hypotension,O
110863,that,O
110863,may,O
110863,likely,O
110863,happen,O
110863,with,O
110863,dialysis,O
110863,.,O
110863,.,O
110863,#,O
110863,.,O
110863,Odynophagia,B-ADE
110863,:,I-ADE
110863,Was,O
110863,presumed,O
110863,due,O
110863,to,O
110863,mucositis,B-ADE
110863,from,O
110863,recent,O
110863,chemotherapy,B-Drug
110863,.,I-Drug
110863,Patient,O
110863,received,O
110863,pain,O
110863,control,O
110863,with,O
110863,narcotics,B-Drug
110863,and,O
110863,was,O
110863,monitored,O
110863,closely,O
110863,for,O
110863,thrush,O
110863,.,O
110863,Pt,O
110863,was,O
110863,also,O
110863,started,O
110863,on,O
110863,Fluc,B-Drug
110863,and,O
110863,Acyclovir,B-Drug
110863,.,I-Drug
110863,.,O
110863,#,O
110863,.,O
110863,CKD,O
110863,:,O
110863,Cr,O
110863,4.0,O
110863,at,O
110863,baseline,O
110863,but,O
110863,urea,O
110863,in,O
110863,the,O
110863,130s,O
110863,from,O
110863,the,O
110863,usual,O
110863,80s,O
110863,.,O
110863,The,O
110863,patient,O
110863,subsequently,O
110863,received,O
110863,one,O
110863,round,O
110863,of,O
110863,dialysis,O
110863,before,O
110863,his,O
110863,goals,O
110863,of,O
110863,care,O
110863,were,O
110863,changed,O
110863,.,O
110863,.,O
110863,#,O
110863,.,O
110863,Kaposi,O
110863,'s,O
110863,sarcoma,O
110863,with,O
110863,known,O
110863,visceral,O
110863,involvement,O
110863,:,O
110863,Patient,O
110863,was,O
110863,pancytopenic,B-ADE
110863,from,O
110863,recent,O
110863,chemotherapy,B-Drug
110863,.,I-Drug
110863,Pt,O
110863,was,O
110863,started,O
110863,on,O
110863,Neupogen,B-Drug
110863,and,O
110863,WBC,O
110863,responded,O
110863,appropriately,O
110863,.,O
110863,.,O
110863,#,O
110863,Pt,O
110863,was,O
110863,on,O
110863,pneumoboots,O
110863,for,O
110863,DVT,O
110863,ppx,O
110863,as,O
110863,pt,O
110863,had,O
110863,thrombocytopenia,O
110863,.,O
110863,Pt,O
110863,was,O
110863,DNR/DNI,O
110863,on,O
110863,admission,O
110863,",",O
110863,then,O
110863,made,O
110863,CMO,O
110863,in,O
110863,ICU,O
110863,.,O
110863,Pt,O
110863,was,O
110863,NPO,O
110863,given,O
110863,high,O
110863,risk,O
110863,of,O
110863,aspiration,O
110863,.,O
110863,Medications,O
110863,on,O
110863,Admission,O
110863,:,O
110863,MEDS,O
110863,ON,O
110863,TRANSFER,O
110863,:,O
110863,hydralazine,B-Drug
110863,25,O
110863,mg,O
110863,tid,B-Frequency
110863,rosuvastatin,O
110863,40,B-Strength
110863,mg,I-Strength
110863,daily,O
110863,ferrous,B-Drug
110863,sulfate,I-Drug
110863,324,O
110863,mg,O
110863,daily,B-Frequency
110863,fluconazole,O
110863,150,B-Strength
110863,mg,I-Strength
110863,IV,O
110863,daily,B-Frequency
110863,Nephrocaps,O
110863,1,B-Dosage
110863,capsule,O
110863,daily,B-Frequency
110863,filgrastim,O
110863,300,B-Strength
110863,mcg,I-Strength
110863,SC,O
110863,daily,B-Frequency
110863,nitroglycerin,O
110863,SL,B-Route
110863,prn,O
110863,labetolol,B-Drug
110863,200,O
110863,mg,O
110863,[,O
110863,**Hospital1,O
110863,**,O
110863,],O
110863,famotidine,B-Drug
110863,20,O
110863,mg,O
110863,[,O
110863,**Hospital1,O
110863,**,O
110863,],O
110863,finasteride,B-Drug
110863,5,O
110863,mg,O
110863,daily,B-Frequency
110863,ranolazine,O
110863,5,B-Strength
110863,mg,I-Strength
110863,daily,O
110863,calcitriol,B-Drug
110863,0.25,O
110863,mg,O
110863,daily,B-Frequency
110863,vitamin,O
110863,D,O
110863,[,O
110863,**2097**,O
110863,],O
110863,units,O
110863,[,O
110863,**Hospital1,O
110863,**,O
110863,],O
110863,.,O
110863,MEDS,O
110863,AT,O
110863,HOME,O
110863,:,O
110863,ondansetron,B-Drug
110863,prn,O
110863,prochlorperazine,B-Drug
110863,prn,O
110863,furosemide,B-Drug
110863,80,O
110863,mg,O
110863,PO,B-Route
110863,bid,O
110863,aspirin,B-Drug
110863,81,O
110863,mg,O
110863,daily,B-Frequency
110863,labetalol,O
110863,200,B-Strength
110863,mg,I-Strength
110863,daily,O
110863,calcitriol,B-Drug
110863,0.25,O
110863,mcg,O
110863,daily,B-Frequency
110863,cholecalciferol,O
110863,(,O
110863,vitamin,O
110863,D3,O
110863,),O
110863,"2,000",B-Strength
110863,unit,I-Strength
110863,daily,O
110863,atorvastatin,B-Drug
110863,80,O
110863,mg,O
110863,daily,B-Frequency
110863,finasteride,O
110863,5,B-Strength
110863,mg,I-Strength
110863,daily,O
110863,ranolazine,B-Drug
110863,SR,O
110863,500,B-Strength
110863,mg,I-Strength
110863,daily,O
110863,ranitidine,B-Drug
110863,150,O
110863,mg,O
110863,qhs,B-Frequency
110863,hydralazine,O
110863,25,B-Strength
110863,mg,I-Strength
110863,q8h,O
110863,epoetin,B-Drug
110863,alfa,I-Drug
110863,"10,000",O
110863,unit/mL,O
110863,1,B-Dosage
110863,injection,O
110863,weekly,B-Frequency
110863,clopidogrel,O
110863,75,B-Strength
110863,mg,I-Strength
110863,daily,O
110863,Renal,B-Drug
110863,Caps,I-Drug
110863,1,O
110863,mg,O
110863,Capsule,B-Form
110863,daily,O
110863,Discharge,O
110863,Disposition,O
110863,:,O
110863,Expired,O
110863,Discharge,O
110863,Diagnosis,O
110863,:,O
110863,Kaposi,O
110863,'s,O
110863,sarcoma,O
110863,CHF,O
110863,ESRD,O
110863,Discharge,O
110863,Condition,O
110863,:,O
110863,expired,O
110863,Completed,O
110863,by,O
110863,:,O
110863,[,O
110863,**2108-12-16**,O
110863,],O
